Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy

Journal of Clinical Oncology

Volumn 29, Issue 16, 2011, Pages 2150-2157

  Von Minckwitz, Gunter ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Müller, Berit Maria ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Loibl, Sibylle ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Budczies, Jan ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Hanusch, Claus ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Darb Esfahani, Silvia ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Hilfrich, Jörn ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Weiss, Erich ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Huober, Jens ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Blohmer, Jens Uwe ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Du Bois, Andreas ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Zahm, Dirk Michael ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Khandan, Fariba ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Hoffmann, Gerald ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Gerber, Bernd ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Eidtmann, Holger ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Fend, Falko ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Dietel, Manfred ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Mehta, Keyur ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Denkert, Carsten ^{a,b,c,d,e,f,g,h,i,j,k,l,m}  

^a c/o GBG Forschungs GmbH ^*  (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MARTIN LUTHER KRANKENHAUS   (Germany)

^d Frauenklinik   (Germany)

^e Frauenklinik   (Germany)

^f Krankenhaus Böblingen   (Germany)

^g UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^h DR HORST SCHMIDT KLINIKEN   (Germany)

ⁱ St Josef Hospital   (Germany)

^j Krankenhaus Gera   (Germany)

^k AGAPLESION MARKUS KRANKENHAUS   (Germany)

^l ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^m UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CYCLOPHOSPHAMIDE; CYTOPLASMIC POLY(ADENOSINE DIPHOSPHATE RIBOSE) POLYMERASE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; NAVELBINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NUCLEAR POLY(ADENOSINE DIPHOSPHATE RIBOSE) POLYMERASE; TRASTUZUMAB; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST ADENOCARCINOMA; BREAST BIOPSY; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PREDICTION; PREDICTIVE VALUE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; CYCLOPHOSPHAMIDE; CYTOPLASM; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MULTICENTER STUDIES AS TOPIC; NEOADJUVANT THERAPY; POLY(ADP-RIBOSE) POLYMERASES; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TAXOIDS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 79957940705     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.31.9079     Document Type: Article

References (29)

1. Gagné JP, Isabelle M, Lo KS, et al: Proteomewide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes. Nucleic Acids Res 36:6959-6976, 2008
2. Audebert M, Salles B, Calsou P: Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA doublestrand breaks rejoining. J Biol Chem 279:55117-55126, 2004 (Pubitemid 40066505)
3. Chang P, Jacobson MK, Mitchison TJ: Poly(ADP-ribose) is required for spindle assembly and structure. Nature 432:645-649, 2004 (Pubitemid 39626273)
4. Huber A, Bai P, de Murcia JM, et al: PARP-1, PARP-2 and ATM in the DNA damage response: Functional synergy in mouse development. DNA Repair (Amst) 3:1103-1108, 2004
5. Kim MY, Mauro S, Gévry N, et al: NAD+- dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. Cell 119:803-814, 2004 (Pubitemid 40017687)
6. Simbulan-Rosenthal CM, Rosenthal DS, Luo R, et al: PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase. Oncogene 22:8460-8471, 2003 (Pubitemid 37523898)
7. Woodhouse BC, Dianov GL: Poly ADP-ribose polymerase-1: An international molecule of mystery. DNA Repair 7:1077-1086, 2008
8. Bernstein C, Bernstein H, Payne CM, et al: DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: Fail-safe protection against carcinogenesis. Mutat Res 511:145-178, 2002 (Pubitemid 34621252)
9. Fisher AE, Hochegger H, Takeda S, et al: Poly(ADP-ribose) polymerase 1 accelerates single-strand break repair in concert with poly(ADP-ribose) glycohydrolase. Mol Cell Biol 27:5597-5605, 2007 (Pubitemid 47124411)
10. Shall S, de Murcia G: Poly(ADP-ribose) polymerase-1: What have we learned from the deficient mouse model? Mutat Res 460:1-15, 2000
11. Bürkle A: Poly(APD-ribosyl)ation, a DNA damage-driven protein modification and regulator of genomic instability. Cancer Lett 163:1-5, 2001
12. Chalmers AJ: The potential role and application of PARP inhibitors in cancer treatment. Br Med Bull 89:23-40, 2009
13. Drew Y, Plummer R: PARP inhibitors in cancer therapy: Two modes of attack on the cancer cell widening the clinical applications. Drug Resistance Updates 12:153-156, 2009
14. Rowe BP, Glazer PM: Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms. Breast Cancer Res 12:203, 2010
15. Farmer H, McCabe N, Lord CJ, et al: Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434:917-921, 2005 (Pubitemid 40559006)
16. Fong PC, Boss DS, Yap TA, et al: Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361:123-134, 2009
17. Schmutzler RK: Familial breast cancer: What are the choices, what are the questions? Breast Care 1:6-7, 2006
18. Dubsky P, Jakesz R: Dissecting the heterogeneity of breast cancer. Breast Care 2:151-156, 2007 (Pubitemid 47014395)
19. Tutt A, Robson M, Garber JE, et al: Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: A proof-of-concept trial. Lancet 376:235-244, 2010
20. O'Shaughnessy J, Osborne C, Pippen JE, et al: Iniparib plus chemotherapy in metastatic triple-negative breast cancer. N Engl J Med 364:205-214, 2011
21. Huober J, von Minckwitz G, Denkert C, et al: Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: Overall results from the GeparTrio study. Breast Cancer Res Treat 124:133-140, 2010
22. von Minckwitz G, Blohmer JU, Raab G, et al: In vivo chemosensitivity- adapted preoperative chemotherapy in patients with early-stage breast cancer: The GEPARTRIO pilot study. Ann Oncol 16:56-63, 2005
23. von Minckwitz G, Kümmel S, Vogel P, et al: Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: Phase III randomized GeparTrio trial. J Natl Cancer Inst 100:542-551, 2008
24. von Minckwitz G, Kümmel S, Vogel P, et al: Intensified neoadjuvant chemotherapy in early-responding breast cancer: Phase III randomized GeparTrio study. J Natl Cancer Inst 100:552-562, 2008
25. Remmele W, Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138-140, 1987
26. Kaufmann SH, Brunet G, Talbot B, et al: Association of poly(ADP-ribose) polymerase with the nuclear matrix: The role of intermolecular disulfide bond formation, RNA retention, and cell type. Exp Cell Res 192:524-535, 1991 (Pubitemid 121006970)
27. Fakan S, Leduc Y, Lamarre D, et al: Immuno-electron microscopical distribution of poly(ADP-ribose) polymerase in the mammalian cell nucleus. Exp Cell Res 179:517-526, 1988 (Pubitemid 19002942)
28. Cookson MR, Ince PG, Usher PA, et al: Poly(ADP-ribose) polymerase is found in both the nucleus and cytoplasm of human CNS neurons. Brain Res 834:182-185, 1999 (Pubitemid 29332028)
29. Rossi MN, Carbone M, Mostocotto C, et al: Mitochondrial localization of PARP-1 requires interaction with mitofilin and is involved in the maintenance of mitochondrial DNA integrity. J Biol Chem 284:31616-31624, 2009